# FDA Inspection 1308346 - Eosera, Inc. - March 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/eosera-inc/6a760a07-14f0-4bff-8ac2-037a6b847e72
Source feed: FDA_Inspections

> FDA Inspection 1308346 for Eosera, Inc. on March 20, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1308346
- Company Name: Eosera, Inc.
- Inspection Date: 2026-03-20
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 1269635 - 2025-04-28](https://www.keypedia.com/records/fda_inspections/eosera-inc/d587b33b-e13d-4322-8bcc-32a754573761)
- [FDA Inspection 1165791 - 2022-03-01](https://www.keypedia.com/records/fda_inspections/eosera-inc/809c8c78-0695-434f-9552-a3a9c12e8c0c)
- [FDA Inspection 1115592 - 2020-01-17](https://www.keypedia.com/records/fda_inspections/eosera-inc/3221668e-fad4-4ca7-b173-8cba754bd210)

Company: https://www.keypedia.com/companies/eosera-inc/703b6159-ec09-448d-a592-b17026014ed1

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9